Staying Safe

The transcript covers a range of topics related to the FDA's regulatory activities, including the Right to Try legislation, balancing regulation and deregulation, nicotine regulation, drug pricing, orphan drugs, modernizing toxicology, and food regulations. The discussion highlights the FDA's efforts to ensure patient safety, promote public health, and foster market competition while addressing challenges in drug approval and pricing.

How does the FDA's regulation of homeopathic therapies differ from traditional therapies?

In what ways does the FDA plan to enhance transparency in its processes?

What concerns are raised regarding the use of electronic cigarettes?

What are the implications of the FDA's approach to orphan drugs?